Sergio Cuevas-Covarrubias,

Dr. Sergio Cuevas-Covarrubias,


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
FMFlavia Morales-Vásquez
Flavia Morales-Vásquez
RSRocio Castillo Sánchez
Rocio Castillo Sánchez
MGMaría J. Gómora
María J. Gómora
MAMiguel Ángel Almaraz
Miguel Ángel Almaraz
EPEnrique Pedernera
Enrique Pedernera
CMCarmen Mendez
Carmen Mendez
Background: The current study evaluated the metalloproteinases MMP-2 and MMP-9 expression in epithelial cells and the surrounding stroma in ovarian tumors and the association of MMPs with the histological subtypes, the clinical stage and the presence of steroid hormone receptors. Tumor samples were obtained from 88 patients undergoing surgical cytoreduction of primary ovarian tumors in Instituto Nacional de Cancerología, from México City. The formalin fixed and paraffin embedded samples were processed in order to demonstrate the presence of androgen receptor,estrogen receptor alpha, progesterone receptor, MMP-2,MMP-9 and collagen IV by immunohistochemistry and/or immunofluorescence. Results: MMP-2 and MMP-9 were differentially expressed in the epithelium and the stroma of ovarian tumors associated to histological subtype, clinical stage and sexual steroid hormone receptor expression. Based on Cox proportional hazard regression model we demonstrated that MMP-2 located in the epithelium and the stroma are independent prognostic biomarkers for overall survival in epithelial ovarian tumors. Kaplan Meir analysis of the combination of AR (+) with MMP-2 (+) in epithelium and AR (+) with MMP-2 (−) in stroma displayed a significant reduction of survival. Conclusions: The presence of MMP-2 in the stroma of the tumor was a protective factor while the presence of MMP-2 in the epithelium indicated an adverse prognosis. The presence of AR associated with MMP-2 in the tumor cells was a risk factor for overall survival in epithelial ovarian cancer.

1 February 2014 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
JVJuan Manuel Valdes-Miranda
Juan Manuel Valdes-Miranda
JSJose Ramon Soto-Alvarez
Jose Ramon Soto-Alvarez
JLJaime Toral López
Jaime Toral López
LGLuz González-Huerta
Luz González-Huerta
APAdrian Perez-Cabrera
Adrian Perez-Cabrera
SCSergio Cuevas-Covarrubias,
Sergio Cuevas-Covarrubias,

19 March 2016 in Molecular Syndromology
Verified
Journal Article
Closed access
PDF file
JLJaime Toral López
Jaime Toral López
LGLuz M. González-Huerta
Luz M. González-Huerta
OBOlga Messina Baas
Olga Messina Baas
SCSergio Cuevas-Covarrubias,
Sergio Cuevas-Covarrubias,
Craniofrontonasal syndrome (CFNS) is a rare genetic entity with X-linked dominant inheritance. CFNS is due to mutations in the Ephrin-B1 (EFNB1) gene. It is characterized by brachycephaly, frontonasal dysplasia, palate/lip defects, dental malocclusion, short neck, split nails, syndactyly, toe and finger defects, and minor skeletal defects. Intelligence is usually unaffected. CFNS exhibits unexpected manifestations between males and females as the latter are more affected. Cellular or metabolic interference due to X inactivation explains the more severe phenotype in heterozygous females. One family with several members affected with CFNS and 100 healthy controls were examined. DNA from leukocytes was isolated to analyze the EFNB1 gene. We did molecular modeling to assess the impact of the mutation on the EFNB1-encoded protein. DNA sequencing analysis of the EFNB1 gene of the affected members showed the heterozygous missense mutation c.451G>A in the EFNB1 gene (GRcH38, chrX: 68,839,708; GERP score in hg38 of 9.961). This transition mutation resulted in the substitution of Gly at position 151 by Ser. Analysis of the healthy members of the family and 100 unrelated controls showed a normal sequence of the EFNB1 gene. Phenotypes of the patients in this family differ from the classical CFNS due to the decreased size of sulci and fissures, subarachnoid space and ventricles, and the absence of a cleft lip/palate.

1 April 2017 in Cancer Research Frontiers
Verified
Journal Article
Open access
LHLuz Huerta
Luz Huerta
CCCarmen Cabrera
Carmen Cabrera
RMRoberto Montes
Roberto Montes
HCHéctor Cuellar
Héctor Cuellar
JLJaime Toral López
Jaime Toral López
HOHospital General de México Service Of Oncology
Hospital General de México Service Of Oncology

1 December 2015 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
MMM. Martínez-Saucedo
M. Martínez-Saucedo
MRM.R. Rivera-Vega
M.R. Rivera-Vega
LHLuz María Gonzalez Huerta
Luz María Gonzalez Huerta
HUH. Urueta-Cuellar
H. Urueta-Cuellar
JLJaime Toral López
Jaime Toral López
SCSergio Cuevas-Covarrubias,
Sergio Cuevas-Covarrubias,

14 September 2015 in Journal of Dermatological Science
Verified
Journal Article
Closed access
PDF file
MVMaria del Refugio Rivera Vega
Maria del Refugio Rivera Vega
MMMauricio R. Murillo-Vilches
Mauricio R. Murillo-Vilches
JLJaime Toral López
Jaime Toral López
ESEtna Guerrero Sanchez
Etna Guerrero Sanchez
ASAndres Tirado Sanchez
Andres Tirado Sanchez
SCSergio Cuevas-Covarrubias,
Sergio Cuevas-Covarrubias,